Completed Digestion, Kidneys & Other Organs Cancer

Development of a novel small molecule for the prevention of allogeneic bone marrow stem cell transplant rejection

Funder Wellcome Charity-funded
Associated organisations Monash University · Peter MacCallum Cancer Centre · Queensland Institute of Medical Research · University of Auckland Europe PMC affiliations are not treated as award recipients or mapped locations.
Funding £1.4M
Period Feb 2012 — Apr 2016

About this grant

This summary is based on the grant title only — the full abstract was not available.

This record describes a research project funded by Wellcome. Europe PMC lists researcher affiliations for this record, not a grant-level recipient.

View the original record at the funder ↗

Researchers

Geoffrey Hill (EPMC Awardee)James Whisstock (EPMC Awardee)Joseph Trapani (EPMC Awardee)Julie Spicer (EPMC Awardee)William Denny (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Development of a cytotopically-modified antithrombotic agent for prevention of acute intra-graft thrombosis in transplantation
Scottish Consortium Translational Medicine and Therapeutics Programme: 'Bone marrow derived cell therapy to enhance regeneration of the liver following resection'.
RATinG (Risk Adapted Therapy in acute GvHD): Investigating the use of lenzilumab for treating high-risk acute graft versus host disease following allogeneic stem cell transplantation
Development of a novel bioartificial device for the treatment of patients with liver failure
19CB17 - Identification of plasmatic markers of graft versus host disease severity in a pediatric population post allogeneic stem cell transplantation

Original classification

Seeding Drug Discovery Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.